Volume | 239,865 |
|
|||||
News | - | ||||||
Day High | 17.52 | Low High |
|||||
Day Low | 16.68 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
REGENXBIO Inc | RGNX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
17.24 | 16.68 | 17.52 | 16.83 | 16.64 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,816 | 239,865 | $ 16.94 | $ 4,063,584 | - | 11.83 - 28.80 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:42:07 | 14 | $ 17.3671 | USD |
REGENXBIO Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
747.27M | 44.43M | - | 90.24M | -263.49M | -5.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
REGENXBIO News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGNX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 16.20 | 17.52 | 15.27 | 16.10 | 367,240 | 0.63 | 3.89% |
1 Month | 19.15 | 19.875 | 15.18 | 17.02 | 415,550 | -2.32 | -12.11% |
3 Months | 16.87 | 28.80 | 15.18 | 20.07 | 717,750 | -0.04 | -0.24% |
6 Months | 14.36 | 28.80 | 11.83 | 18.48 | 646,106 | 2.47 | 17.20% |
1 Year | 19.49 | 28.80 | 11.83 | 18.30 | 515,131 | -2.66 | -13.65% |
3 Years | 34.79 | 46.46 | 11.83 | 24.53 | 435,368 | -17.96 | -51.62% |
5 Years | 50.27 | 55.23 | 11.83 | 30.72 | 443,785 | -33.44 | -66.52% |
REGENXBIO Description
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). |